This inventor holds 1 USPTO granted patent. Top assignee: Biosense Webster, Inc.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Hendrikus Willem Wegereef: Innovator in Cryoablation Technology
Introduction
Hendrikus Willem Wegereef is a notable inventor based in Peize, Netherlands. He has made significant contributions to the field of medical technology, particularly in the development of cryoablation devices. His innovative work has the potential to enhance treatment options for patients with various medical conditions.
Latest Patents
Wegereef holds a patent for a cryoablation catheter designed for long lesion ablations. The patent describes a cryoablation catheter that features an outer tubular body with a closed distal end, forming a fluid cooling chamber. It also includes an inner tubular member with a proximal end that receives fluid suitable for cryoablation and a distal end coupled to a fluid expansion nozzle. The design allows the inner tubular member to move in an axial direction, changing the position of the nozzle within the fluid cooling chamber. This innovation aims to improve the efficacy and precision of cryoablation procedures.
Career Highlights
Hendrikus Willem Wegereef is associated with Biosense Webster, Inc., a company known for its advancements in electrophysiology and cardiac mapping technologies. His work at the company has been instrumental in developing cutting-edge medical devices that improve patient outcomes.
Collaborations
Wegereef collaborates with various professionals in the medical field, including his coworker Bart-Jan Korteling. Their combined expertise contributes to the ongoing innovation in medical technology.
Conclusion
Hendrikus Willem Wegereef's contributions to cryoablation technology exemplify the impact of innovative thinking in the medical field. His patent for a cryoablation catheter represents a significant advancement that could enhance treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
